The United States would equitably integrate AstraZeneca's COVID-19 vaccine into the distribution system if the vaccine is approved by U.S. authorities, White House Press Secretary Jen Psaki said on Monday. She noted there was still a vaccine shortage in the United States and some 1,400 people were still dying each day. AstraZeneca's COVID-19 vaccine performed better than expected in a major late-stage trial, the drugmaker said on Monday, potentially paving the way for its emergency authorization in the United States. This story has been published from a wire agency feed without modifications to the text. Subscribe to Mint Newsletters * Enter a valid email * Thank you for subscribing to our newsletter.

Source: Mint March 22, 2021 16:41 UTC